Recombinant anti-mouse CD90.2 / Thy1.2 monoclonal antibody (Clone 30-H12), engineered with a Human IgG1 Fc-Silent domain to eliminate ADCC/CDC and minimize non-specific Fc receptor binding during in vivo T cell targeting and functional blocking studies....
Recombinant rat anti-mouse CD90.2 / Thy1.2 monoclonal antibody (Clone 30-H12), engineered with a Rat IgG2b Fc domain for in vivo T cell depletion, functional blocking, and flow cytometry studies. Variable regions are derived from the...
Recombinant anti-mouse integrin beta 7 monoclonal antibody (Clone FIB21, Biotinylated), engineered with a Human IgG1 Fc-Silent domain to minimize non-specific Fc receptor binding during flow cytometry and cell adhesion assays. Variable regions are derived from...
Recombinant anti-mouse integrin beta 7 monoclonal antibody (Clone FIB21), engineered with a Human IgG1 Fc-Silent domain to eliminate ADCC/CDC and minimize non-specific Fc receptor binding during in vivo leukocyte trafficking and gut homing studies. Variable...
Recombinant rat anti-mouse integrin beta 7 monoclonal antibody (Clone FIB21), engineered with a Rat IgG2a Fc domain for in vivo leukocyte trafficking, gut homing, and cell adhesion blocking studies. Variable regions are derived from the...
Recombinant anti-mouse MHC Class II (I-A/I-E) monoclonal antibody (Clone M5/114.15.2, Biotinylated), engineered with a Human IgG1 Fc-Silent domain to minimize non-specific Fc receptor binding during flow cytometry and antigen presentation assays. Variable regions are derived...
Recombinant anti-mouse MHC Class II (I-A/I-E) monoclonal antibody (Clone M5/114.15.2), engineered with a Human IgG1 Fc-Silent domain to eliminate ADCC/CDC and minimize non-specific Fc receptor binding during in vivo antigen presentation blocking and immunomodulation studies....
Recombinant rat anti-mouse MHC Class II (I-A/I-E) monoclonal antibody (Clone M5/114.15.2), engineered with a Rat IgG2b Fc domain for in vivo antigen presentation blocking and dendritic cell/B cell depletion studies. Variable regions are derived from...
Recombinant anti-mouse CD44 monoclonal antibody (Clone IM7.8.1, Biotinylated), engineered with a Human IgG1 Fc-Silent domain to minimize non-specific Fc receptor binding during flow cytometry and lymphocyte homing analysis. Variable regions are derived from the anti-mouse...
Recombinant anti-mouse CD44 monoclonal antibody (Clone IM7.8.1), engineered with a Human IgG1 Fc-Silent domain to eliminate ADCC/CDC and minimize non-specific Fc receptor binding during in vivo adhesion, cell migration, and lymphocyte homing studies. Variable regions...
